MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…
Biotechnology
CH, Zug [HQ]
Cash Flow Statements
4 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Cash Flow (OCF) | - - | -35.00 | -55.00 | -42.00 | |
| Operating Cash (Net) | - - | -35.00 | -55.00 | -42.00 | |
| Accounts Receivable | - - | - - | - - | - - | |
| Accounts Payable | - - | 1.00 | -1.00 | - - | |
|
Working Capital
|
- - | - - | - - | - - | |
| Change | - - | 4.00 | -1.00 | -6.00 | |
| Other WC | - - | 3.00 | - - | -5.00 | |
| Investing Activities | |||||
| Used Cash (Net) | -115.00 | - - | -32.00 | -25.00 | |
| Capital Expenditure | - - | - - | - - | - - | |
| Purchases of Investments | -115.00 | - - | -42.00 | -175.00 | |
| Sale/Maturity of Investment | - - | - - | 9.00 | 150.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | - - | |
| Financing Activities | |||||
| Used Cash (Net) | -116.00 | -43.00 | -119.00 | -479.00 | |
| Debt Repayment | - - | -15.00 | -15.00 | - - | |
| Dividends Paid | - - | - - | - - | - - | |
|
Common Stock
|
- - | 28 | - - | - - | |
| Issued | 117.00 | 28.00 | - - | 482.00 | |
| Repurchased | - - | - - | - - | - - | |
| Other Financing Activities | - - | - - | 134.00 | -2.00 | |
| Cash Balances | |||||
| Begin of Period | - - | 1.00 | 8.00 | 39.00 | |
| End of Period | 1.00 | 8.00 | 39.00 | 451.00 | |
| Change | 1.00 | 6.00 | 31.00 | 411.00 | |
| Non-Cash Balances | |||||
| Depreciation and Amortization | - - | - - | - - | - - | |
| Stock Based Compensation | - - | - - | 9.00 | 7.00 | |
| Other | - - | 12.00 | - - | - - | |
| Highlighted metrics | |||||
| Free Cash Flow (FCF) | - - | -35.00 | -55.00 | -43.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | |
| Invested Capital | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||
| Forex Effect on Cash | - - | - - | - - | - - |